Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive Clinical Trial

Official title:
A Multi-centre, Randomized, Double-blind, Active Control, Parallel-group, 2-arm Study to Investigate the Effect of Ethinylestradiol / Drospirenone (0.02 mg/3 mg) Oral Contraception in a 24/4 Regimen Compared to Ethinylestradiol / Desogestrel (0.02 mg/0.15 mg) Oral Contraception in a 21/7 Regimen on Hormone Withdrawal Associated Symptoms in Otherwise Healthy Women After 4 Cycles of Treatment

Status Completed

Clinical Trial Summary

This clinical research study will examine whether an oral contraceptive pill taken with a monthly hormone-free interval of 4 days reduces hormone withdrawal associated symptoms compared to an oral contraceptive pill taken with a monthly hormone-free interval of 7 days after 4 cycles of treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Oral Contraceptive

Clinical Trial Details

NCT number	NCT01076582
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 3
Start date	April 2010
Completion date	October 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01388491` - A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women	Phase 2
Completed	`NCT01252186` - A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women	Phase 2
Not yet recruiting	`NCT06426459` - Social Media Usage in Adolescent Girls
Recruiting	`NCT02398903` - Evaluation of Hormonal Contraceptive Treatments in Obese Women
Completed	`NCT00302666` - Bleeding Pattern Study	Phase 3
Completed	`NCT00739622` - TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.	Phase 1
Completed	`NCT01291004` - A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives	Phase 1
Recruiting	`NCT01318005` - Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation	N/A
Recruiting	`NCT02021097` - Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception	Phase 3
Completed	`NCT00778609` - Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache	Phase 3
Completed	`NCT00972439` - Oral Contraceptive (OC) Progestin Dose and Breast Proliferation	N/A
Completed	`NCT00471991` - Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition	Phase 2
Completed	`NCT00248963` - Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception	Phase 3